NeuroBo Pharmaceuticals Begins Phase 2a Clinical Trial for Experimental Drug DA1241 in Treating NASH
On September 15, 2023, NeuroBo Pharmaceuticals achieved a significant milestone by administering the initial dose of its experimental drug, DA-1241, ...